Logo image of HUN

HUNTSMAN CORP (HUN) Stock Fundamental Analysis

USA - NYSE:HUN - US4470111075 - Common Stock

9.095 USD
-0.29 (-3.14%)
Last: 10/7/2025, 2:35:07 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to HUN. HUN was compared to 83 industry peers in the Chemicals industry. HUN may be in some trouble as it scores bad on both profitability and health. HUN is valued expensive and it does not seem to be growing. Finally HUN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

HUN had negative earnings in the past year.
In the past year HUN had a positive cash flow from operations.
Of the past 5 years HUN 4 years were profitable.
In the past 5 years HUN always reported a positive cash flow from operatings.
HUN Yearly Net Income VS EBIT VS OCF VS FCFHUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

The Return On Assets of HUN (-4.72%) is worse than 71.08% of its industry peers.
HUN has a worse Return On Equity (-12.03%) than 69.88% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.72%, HUN is doing worse than 77.11% of the companies in the same industry.
HUN had an Average Return On Invested Capital over the past 3 years of 3.85%. This is below the industry average of 6.37%.
Industry RankSector Rank
ROA -4.72%
ROE -12.03%
ROIC 0.72%
ROA(3y)1.44%
ROA(5y)5.47%
ROE(3y)3.16%
ROE(5y)12.59%
ROIC(3y)3.85%
ROIC(5y)4.46%
HUN Yearly ROA, ROE, ROICHUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

The Operating Margin of HUN (0.87%) is worse than 79.52% of its industry peers.
HUN's Operating Margin has declined in the last couple of years.
The Gross Margin of HUN (13.74%) is worse than 75.90% of its industry peers.
In the last couple of years the Gross Margin of HUN has declined.
Industry RankSector Rank
OM 0.87%
PM (TTM) N/A
GM 13.74%
OM growth 3Y-50.02%
OM growth 5Y-28.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.43%
GM growth 5Y-6.74%
HUN Yearly Profit, Operating, Gross MarginsHUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

2

2. Health

2.1 Basic Checks

HUN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HUN has more shares outstanding
HUN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for HUN is higher compared to a year ago.
HUN Yearly Shares OutstandingHUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
HUN Yearly Total Debt VS Total AssetsHUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

HUN has an Altman-Z score of 1.57. This is a bad value and indicates that HUN is not financially healthy and even has some risk of bankruptcy.
HUN has a Altman-Z score of 1.57. This is in the lower half of the industry: HUN underperforms 66.27% of its industry peers.
The Debt to FCF ratio of HUN is 15.19, which is on the high side as it means it would take HUN, 15.19 years of fcf income to pay off all of its debts.
HUN has a Debt to FCF ratio of 15.19. This is comparable to the rest of the industry: HUN outperforms 51.81% of its industry peers.
HUN has a Debt/Equity ratio of 0.59. This is a neutral value indicating HUN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.59, HUN is in the better half of the industry, outperforming 61.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 15.19
Altman-Z 1.57
ROIC/WACC0.09
WACC7.89%
HUN Yearly LT Debt VS Equity VS FCFHUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

HUN has a Current Ratio of 1.43. This is a normal value and indicates that HUN is financially healthy and should not expect problems in meeting its short term obligations.
HUN has a worse Current ratio (1.43) than 74.70% of its industry peers.
A Quick Ratio of 0.85 indicates that HUN may have some problems paying its short term obligations.
HUN has a Quick ratio of 0.85. This is in the lower half of the industry: HUN underperforms 77.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.85
HUN Yearly Current Assets VS Current LiabilitesHUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

3

3. Growth

3.1 Past

HUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2400.00%.
HUN shows a decrease in Revenue. In the last year, the revenue decreased by -1.56%.
Measured over the past years, HUN shows a decrease in Revenue. The Revenue has been decreasing by -2.35% on average per year.
EPS 1Y (TTM)-2400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-242.86%
Revenue 1Y (TTM)-1.56%
Revenue growth 3Y-7.68%
Revenue growth 5Y-2.35%
Sales Q2Q%-7.37%

3.2 Future

The Earnings Per Share is expected to grow by 108.55% on average over the next years. This is a very strong growth
Based on estimates for the next years, HUN will show a small growth in Revenue. The Revenue will grow by 1.22% on average per year.
EPS Next Y-859.95%
EPS Next 2Y-9.06%
EPS Next 3Y108.55%
EPS Next 5YN/A
Revenue Next Year-4.39%
Revenue Next 2Y-0.05%
Revenue Next 3Y1.22%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HUN Yearly Revenue VS EstimatesHUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
HUN Yearly EPS VS EstimatesHUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HUN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HUN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HUN Price Earnings VS Forward Price EarningsHUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

HUN's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, HUN is valued cheaper than 85.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.79
EV/EBITDA 9.7
HUN Per share dataHUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as HUN's earnings are expected to grow with 108.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.06%
EPS Next 3Y108.55%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.76%, HUN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.61, HUN pays a better dividend. On top of this HUN pays more dividend than 97.59% of the companies listed in the same industry.
HUN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 10.76%

5.2 History

The dividend of HUN is nicely growing with an annual growth rate of 9.05%!
HUN has been paying a dividend for at least 10 years, so it has a reliable track record.
HUN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)9.05%
Div Incr Years4
Div Non Decr Years17
HUN Yearly Dividends per shareHUN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

HUN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
HUN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-51.63%
EPS Next 2Y-9.06%
EPS Next 3Y108.55%
HUN Yearly Income VS Free CF VS DividendHUN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

HUNTSMAN CORP

NYSE:HUN (10/7/2025, 2:35:07 PM)

9.095

-0.29 (-3.14%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners93%
Inst Owner Change0%
Ins Owners5.31%
Ins Owner Change0.85%
Market Cap1.58B
Analysts55
Price Target10.75 (18.2%)
Short Float %9.07%
Short Ratio3
Dividend
Industry RankSector Rank
Dividend Yield 10.76%
Yearly Dividend1.01
Dividend Growth(5Y)9.05%
DP-51.63%
Div Incr Years4
Div Non Decr Years17
Ex-Date09-15 2025-09-15 (0.25)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.68%
Min EPS beat(2)-64.52%
Max EPS beat(2)-0.84%
EPS beat(4)1
Avg EPS beat(4)-53.28%
Min EPS beat(4)-152.09%
Max EPS beat(4)4.35%
EPS beat(8)1
Avg EPS beat(8)-32.62%
EPS beat(12)2
Avg EPS beat(12)-27.18%
EPS beat(16)6
Avg EPS beat(16)-17.7%
Revenue beat(2)0
Avg Revenue beat(2)-4.85%
Min Revenue beat(2)-6.25%
Max Revenue beat(2)-3.44%
Revenue beat(4)0
Avg Revenue beat(4)-2.94%
Min Revenue beat(4)-6.25%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.96%
Revenue beat(12)2
Avg Revenue beat(12)-2.01%
Revenue beat(16)3
Avg Revenue beat(16)-2.37%
PT rev (1m)-2.14%
PT rev (3m)-25.14%
EPS NQ rev (1m)-3.45%
EPS NQ rev (3m)-381.66%
EPS NY rev (1m)-3.9%
EPS NY rev (3m)-74.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.27%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-3.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF 11.79
P/OCF 5.29
P/B 0.56
P/tB 0.86
EV/EBITDA 9.7
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.77
FCFY8.48%
OCF(TTM)1.72
OCFY18.92%
SpS33.73
BVpS16.12
TBVpS10.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.72%
ROE -12.03%
ROCE 0.91%
ROIC 0.72%
ROICexc 0.77%
ROICexgc 0.95%
OM 0.87%
PM (TTM) N/A
GM 13.74%
FCFM 2.29%
ROA(3y)1.44%
ROA(5y)5.47%
ROE(3y)3.16%
ROE(5y)12.59%
ROIC(3y)3.85%
ROIC(5y)4.46%
ROICexc(3y)4.26%
ROICexc(5y)5.51%
ROICexgc(3y)5.21%
ROICexgc(5y)6.86%
ROCE(3y)4.87%
ROCE(5y)5.65%
ROICexcg growth 3Y-54.19%
ROICexcg growth 5Y-26.52%
ROICexc growth 3Y-53.71%
ROICexc growth 5Y-28.3%
OM growth 3Y-50.02%
OM growth 5Y-28.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.43%
GM growth 5Y-6.74%
F-Score5
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 15.19
Debt/EBITDA 4.93
Cap/Depr 57.69%
Cap/Sales 2.82%
Interest Coverage 0.64
Cash Conversion 88.72%
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 0.85
Altman-Z 1.57
F-Score5
WACC7.89%
ROIC/WACC0.09
Cap/Depr(3y)81.07%
Cap/Depr(5y)89.35%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-242.86%
EPS Next Y-859.95%
EPS Next 2Y-9.06%
EPS Next 3Y108.55%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.56%
Revenue growth 3Y-7.68%
Revenue growth 5Y-2.35%
Sales Q2Q%-7.37%
Revenue Next Year-4.39%
Revenue Next 2Y-0.05%
Revenue Next 3Y1.22%
Revenue Next 5YN/A
EBIT growth 1Y142.86%
EBIT growth 3Y-53.86%
EBIT growth 5Y-29.79%
EBIT Next Year112.18%
EBIT Next 3Y57.81%
EBIT Next 5YN/A
FCF growth 1Y-46.18%
FCF growth 3Y-49.41%
FCF growth 5Y-33.84%
OCF growth 1Y-37.71%
OCF growth 3Y-34.87%
OCF growth 5Y-21.76%